BioCardia raises $4.4M via ATM share sale, extends cash runway into Q1 2027

BioCardia, Inc.

Sold 3,509,604 shares at average $1.279 on June 5, 2026; net proceeds ~$4.4M.
Proceeds expected to extend cash runway into Q1 2027, beyond planned Japan PMDA submission.
If outstanding warrants from prior financings exercised for cash, runway would extend beyond PMDA approval into first commercial sales.
No warrants were issued in this capital raise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.